ETrade Capital Management’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$248K Sell
10,155
-259
-2% -$6.05K ﹤0.01% 764
2020
Q2
$247K Sell
10,414
-619
-6% -$14.3K 0.01% 711
2020
Q1
$190K Sell
11,033
-588
-5% -$10.8K ﹤0.01% 692
2019
Q4
$205K Sell
11,621
-1,380
-11% -$23.4K ﹤0.01% 767
2019
Q3
$230K Buy
13,001
+560
+5% +$11.3K 0.01% 741
2019
Q2
$266K Sell
12,441
-36,660
-75% -$768K 0.01% 710
2019
Q1
$1.17M Buy
49,101
+33,555
+216% +$765K 0.03% 294
2018
Q4
$306K Buy
+15,546
New +$277K 0.01% 616

Other funds holding EXEL

ETrade Capital Management's EXEL Position: Q3 2020 in Review

ETrade Capital Management reduced its Exelixis (EXEL) stake by 2.5% in Q3 2020, selling an estimated $6.05K and leaving 10,155 shares worth $248K. The position accounts for ﹤0.01% of the portfolio, ranked #764.

ETrade Capital Management first reported a position in EXEL in Q4 2018 and has held it in 8 quarters since. The position peaked at $1.17M in Q1 2019. 368 funds tracked by Wall St. Rank hold EXEL as of Q3 2020.

  • ETrade Capital Management held 10,155 shares of Exelixis worth $248K as of Q3 2020.
  • ETrade Capital Management sold 259 Exelixis shares in Q3 2020, an estimated $6.05K.
  • Exelixis made up ﹤0.01% of ETrade Capital Management's portfolio in Q3 2020, its #764 holding.
  • ETrade Capital Management first reported a position in Exelixis in Q4 2018 and has held it in 8 quarters since.
  • ETrade Capital Management's Exelixis position peaked at $1.17M in Q1 2019.
  • 368 funds tracked by Wall St. Rank held Exelixis as of Q3 2020.

Based on ETrade Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.